SPARCL1 and cardiomyopathy: Furthermore, they compared the genes with consistent change across all three cardiomyopathies to the druggable genome [56], resulting in 39 druggable genes (10 up-regulated and 29 down-regulated) including CYD2J2, MYH6, COL14A1, and SPARCL1 [55].